Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High‐risk Otolaryngologic Devices, 2000‐2014

Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital • Harvard Medical School
41 Avenue Louis Pasteur, Suite 0B17, Boston, MA 02115